Cargando…
Novel compounds in the treatment of lung cancer: current and developing therapeutic agents
Lung cancer is the leading cause of cancer-related death in the United States. Though incremental advances have been made in the treatment of this devastating disease during the past decade, new therapies are urgently needed. Traditional cytotoxic agents have been combined with other modalities with...
Autores principales: | Bao, Rudi, Chan, Pokman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863377/ https://www.ncbi.nlm.nih.gov/pubmed/27186107 http://dx.doi.org/10.2147/JEP.S7804 |
Ejemplares similares
-
Current therapy and development of therapeutic agents for lung cancer
por: Wang, Zilai, et al.
Publicado: (2022) -
Current and developing therapeutic agents in the treatment of Chagas disease
por: Apt, Werner
Publicado: (2010) -
Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents
por: Wilton, Steve D, et al.
Publicado: (2011) -
A recent development of new therapeutic agents and novel drug targets for cancer treatment
por: Kifle, Zemene Demelash, et al.
Publicado: (2021) -
Therapeutic Potential of the Natural Compound S-Adenosylmethionine as a Chemoprotective Synergistic Agent in Breast, and Head and Neck Cancer Treatment: Current Status of Research
por: Mosca, Laura, et al.
Publicado: (2020)